\-\ Texto\\:\\ \ \(0\)\
\-\ none\\.\ \(8\)\
\-\ this\\ patient\\ was\\ stage\\ 1\\ sarcoid\\ and\\ was\\ began\\ on\\ a\\ steroid\\ regimen\\ with\\ radiographic\\ followup\\.\ \(0\)\
\-\ bilateral\\ and\\ symmetric\\ hilar\\ adenopathy\ \(1\)\
\-\ pulmonary\\ sarcoidosis\ \(3\)\
\-\ sarcoid\ \(163\)\
\-\ lymphoma\\,\\ hodgkin\\â\\€\\™s\\ and\\ nhl\ \(0\)\
\-\ castleman\\â\\€\\™s\\ disease\ \(0\)\
\-\ metastic\\ disease\ \(2\)\
\-\ severe\\ infection\ \(0\)\
\-\ 32\\ yo\\ man\\ with\\ shortness\\ of\\ breath\\.\ \(1\)\
\-\ this\\ is\\ a\\ good\\ example\\ of\\ stage\\ 1\\ sarcoid\\,\\ bilateral\\ symmetric\\ hilar\\ adenopathy\\.\\ \\ the\\ patient\\â\\€\\™s\\ shortness\\ of\\ breath\\ resolved\\ with\\ bronchodilators\\ and\\ is\\ scheduled\\ for\\ continued\\ radiographic\\ followup\\ and\\ was\\ put\\ on\\ a\\ steroid\\ regimen\\.\ \(0\)\
\-\ stages\\ based\\ on\\ cxr\\:\ \(0\)\
\-\ stage\\ 0\\:\\ normal\\ film\\,\\ 10\\%\ \(0\)\
\-\ stage\\ 1\\:\\ adenopathy\\,\\ 50\\%\ \(0\)\
\-\ \\	symmetric\\ hilar\\ adenopathy\ \(0\)\
\-\ \\	paratracheal\\,\\ tracheobronchial\\,\\ and\\ azygos\\ adenpathy\\ is\\ commonly\\ associated\\ with\\ hilar\\ adenopathy\ \(0\)\
\-\ \\	calcification\\,\\ 5\\%\ \(0\)\
\-\ stage\\ 2\\:\\ adenopathy\\ with\\ pulmonary\\ opacities\\,\\ 30\\%\ \(0\)\
\-\ \\	reticulonodular\\ pattern\ \(0\)\
\-\ \\	acinar\\ pattern\\ may\\ coalesce\\ to\\ consolidation\ \(0\)\
\-\ \\	large\\ nodules\\ \\>1cm\\ \\(2\\%\\)\ \(0\)\
\-\ stage\\ 3\\:\\ pulmonary\\ opacities\\ without\\ hilar\\ adenopathy\\,\\ 10\\%\ \(0\)\
\-\ stage\\ 4\\:\\ pulmonary\\ fibrosis\\,\\ upper\\ lobes\\ with\\ bullae\ \(0\)\
\-\ other\\ less\\ common\\ plain\\ film\\ findings\\:\ \(0\)\
\-\ \\	pleural\\ effusion\\,\\ 10\\%\ \(0\)\
\-\ \\	unilateral\\ hilar\\ adenopathy\\,\\ 1\\-3\\%\ \(0\)\
\-\ \\	eggshell\\ calcification\\ of\\ lymph\\ nodes\ \(0\)\
\-\ \\	complications\\ of\\ stage\\ 3\\ include\\ pneumothorax\\ \\(blebs\\,\\ bullae\\)\\ and\\ aspergillus\\ with\\ fungus\\ ball\ \(0\)\
\-\ \\	bronchostenosis\\ with\\ lobar\\/segmental\\ collapse\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ adenopathy\\:\\ 0\\.4283271546894106\ \(0\)\
\-\ stage\\:\\ 0\\.4055003795490217\ \(0\)\
\-\ hilar\\:\\ 0\\.3501880799059736\ \(0\)\
\-\ sarcoid\\:\\ 0\\.17907946961723614\ \(0\)\
\-\ symmetric\\:\\ 0\\.16363624611962502\ \(0\)\
\-\ bullae\\:\\ 0\\.16180849887609905\ \(0\)\
\-\ pulmonary\\:\\ 0\\.15519013784677538\ \(0\)\
\-\ regimen\\:\\ 0\\.14101965483663528\ \(0\)\
\-\ steroid\\:\\ 0\\.1226984843686631\ \(0\)\
\-\ opacities\\:\\ 0\\.12153894017237146\ \(0\)\
\-\ followup\\:\\ 0\\.11239653450892363\ \(0\)\
\-\ 10\\:\\ 0\\.11165764635374668\ \(0\)\
\-\ shortness\\:\\ 0\\.1020725330612205\ \(0\)\
\-\ adenpathy\\:\\ 0\\.10179001017798148\ \(0\)\
\-\ bronchostenosis\\:\\ 0\\.10179001017798148\ \(0\)\
\-\ with\\:\\ 0\\.09970753349310411\ \(0\)\
\-\ film\\:\\ 0\\.09512744949031032\ \(0\)\
\-\ pattern\\:\\ 0\\.09504111976870974\ \(0\)\
\-\ radiographic\\:\\ 0\\.09444598569440986\ \(0\)\
\-\ bronchodilators\\:\\ 0\\.09405580281922246\ \(0\)\
\-\ acinar\\:\\ 0\\.09405580281922246\ \(0\)\
\-\ eggshell\\:\\ 0\\.09405580281922246\ \(0\)\
\-\ breath\\:\\ 0\\.09330131401130005\ \(0\)\
\-\ and\\:\\ 0\\.09206727495007219\ \(0\)\
\-\ calcification\\:\\ 0\\.09088639745067562\ \(0\)\
\-\ nhl\\:\\ 0\\.08781155243991423\ \(0\)\
\-\ metastic\\:\\ 0\\.08781155243991423\ \(0\)\
\-\ tracheobronchial\\:\\ 0\\.08632159546046345\ \(0\)\
\-\ blebs\\:\\ 0\\.08632159546046345\ \(0\)\
\-\ coalesce\\:\\ 0\\.08383173681999434\ \(0\)\
\-\ azygos\\:\\ 0\\.0817973741827878\ \(0\)\
\-\ aspergillus\\:\\ 0\\.08090424943804952\ \(0\)\
\-\ castleman\\:\\ 0\\.08007734508115522\ \(0\)\
\-\ reticulonodular\\:\\ 0\\.07791093235128808\ \(0\)\
\-\ fungus\\:\\ 0\\.07727315290511216\ \(0\)\
\-\ put\\:\\ 0\\.07609752946123532\ \(0\)\
\-\ paratracheal\\:\\ 0\\.07050982741831764\ \(0\)\
\-\ bilateral\\:\\ 0\\.06841558544421894\ \(0\)\
\-\ stages\\:\\ 0\\.06808779939768919\ \(0\)\
\-\ 1cm\\:\\ 0\\.06755636074034883\ \(0\)\
\-\ ball\\:\\ 0\\.06755636074034883\ \(0\)\
\-\ was\\:\\ 0\\.06654783704804712\ \(0\)\
\-\ hodgkin\\:\\ 0\\.0650147242686775\ \(0\)\
\-\ example\\:\\ 0\\.06347322861745054\ \(0\)\
\-\ of\\:\\ 0\\.06227999615033075\ \(0\)\
\-\ collapse\\:\\ 0\\.05969315653907872\ \(0\)\
\-\ began\\:\\ 0\\.05919158434122325\ \(0\)\
\-\ scheduled\\:\\ 0\\.05906963665088398\ \(0\)\
\-\ consolidation\\:\\ 0\\.05882966820645549\ \(0\)\
\-\ unilateral\\:\\ 0\\.05825139878188297\ \(0\)\
\-\ on\\:\\ 0\\.0576700662938595\ \(0\)\
\-\ resolved\\:\\ 0\\.05717767652661336\ \(0\)\
\-\ pneumothorax\\:\\ 0\\.05547228100426075\ \(0\)\
\-\ 32\\:\\ 0\\.05454541537320834\ \(0\)\
\-\ nodes\\:\\ 0\\.05407053082883511\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.05391662352526436\ \(0\)\
\-\ disease\\:\\ 0\\.053435914494655075\ \(0\)\
\-\ fibrosis\\:\\ 0\\.05332138359916701\ \(0\)\
\-\ lobes\\:\\ 0\\.05310610806130666\ \(0\)\
\-\ is\\:\\ 0\\.05229285388394596\ \(0\)\
\-\ continued\\:\\ 0\\.0521530080299209\ \(0\)\
\-\ good\\:\\ 0\\.051768207738978896\ \(0\)\
\-\ cxr\\:\\ 0\\.050918811734473685\ \(0\)\
\-\ nodules\\:\\ 0\\.05057368826585844\ \(0\)\
\-\ lymph\\:\\ 0\\.04949477087938329\ \(0\)\
\-\ complications\\:\\ 0\\.04874896309923633\ \(0\)\
\-\ pleural\\:\\ 0\\.047915190104020046\ \(0\)\
\-\ effusion\\:\\ 0\\.04726501964868436\ \(0\)\
\-\ commonly\\:\\ 0\\.047097853936308616\ \(0\)\
\-\ based\\:\\ 0\\.04610625134789428\ \(0\)\
\-\ 50\\:\\ 0\\.04445147449422135\ \(0\)\
\-\ this\\:\\ 0\\.04374248805681799\ \(0\)\
\-\ 30\\:\\ 0\\.04342076351054086\ \(0\)\
\-\ less\\:\\ 0\\.04330205917185123\ \(0\)\
\-\ plain\\:\\ 0\\.0419943856353138\ \(0\)\
\-\ patient\\:\\ 0\\.04140421948010377\ \(0\)\
\-\ severe\\:\\ 0\\.04029312542389583\ \(0\)\
\-\ yo\\:\\ 0\\.039764832552480374\ \(0\)\
\-\ infection\\:\\ 0\\.03844820880774633\ \(0\)\
\-\ lymphoma\\:\\ 0\\.03790744304648402\ \(0\)\
\-\ include\\:\\ 0\\.037871097403267384\ \(0\)\
\-\ common\\:\\ 0\\.03609677085822773\ \(0\)\
\-\ none\\:\\ 0\\.03478425533530793\ \(0\)\
\-\ upper\\:\\ 0\\.034013508604197516\ \(0\)\
\-\ man\\:\\ 0\\.033697035246466917\ \(0\)\
\-\ without\\:\\ 0\\.03357291714129846\ \(0\)\
\-\ associated\\:\\ 0\\.03354825834098265\ \(0\)\
\-\ other\\:\\ 0\\.033054403094911054\ \(0\)\
\-\ may\\:\\ 0\\.03203062519372135\ \(0\)\
\-\ large\\:\\ 0\\.031891748021517057\ \(0\)\
\-\ findings\\:\\ 0\\.031413767382853355\ \(0\)\
\-\ normal\\:\\ 0\\.02598781804955734\ \(0\)\
\-\ for\\:\\ 0\\.01929178927107597\ \(0\)\
\-\ to\\:\\ 0\\.015912344259462943\ \(0\)\
\-\ the\\:\\ 0\\.012700456823241342\ \(0\)\
